Vancouver-based Chinese biotechnology firm Virogin Biotech has pocketed $62 million in a Series C round co-led by Chinese alternative management firm CDH Investments and CMG-SDIC Fund, a joint fund of state-owned SDIC Fund Management and China Merchants Capital.
Continue reading this premium story with a subscription to DealStreetAsia.Subscribe
Already a Subscriber? Log in
Contact us for corporate subscriptions at email@example.com